ZyVersa Therapeutics (ZVSA) Stock Chart & Stock Price History $0.14 -0.04 (-22.54%) As of 07/18/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZyVersa Therapeutics Stock Price Performance The ZyVersa Therapeutics (ZVSA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 96.34%, with a year-to-date return of -86.51%. In the past month, the stock has decreased 77.86%, reflecting recent market activity. As of the latest close, ZyVersa Therapeutics traded at $0.14 with a market cap of $696 thousand and volume of 635,472 shares. Receive ZVSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-73.95%1 Month Performance-77.86%3 Month Performance-79.55%Year-To-Date Performance-86.51%1 Year Performance-96.34% ZVSA Stock Chart for Sunday, July, 20, 2025 ZVSA Chart by TradingView ZyVersa Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025$0.18$0.14-22.54%$0.19$0.14635,472 shs$696,000.0007/17/2025$0.31$0.18-40.70%$0.25$0.151.71 million shs$900,000.0007/16/2025$0.55$0.31-43.30%$0.56$0.2711.92 million shs$1.52 million07/15/2025$0.57$0.55-3.31%$0.56$0.53466,579 shs$2.62 million07/14/2025$0.59$0.57-3.76%$0.57$0.55702,720 shs$2.71 million07/11/2025$0.59$0.59$0.59$0.561.07 million shs$2.82 million07/10/2025$0.64$0.59-7.81%$0.67$0.561.76 million shs$2.81 million07/09/2025$0.78$0.64-17.42%$0.70$0.624.22 million shs$3.05 million07/08/2025$0.66$0.78+17.37%$1.67$0.70207.52 million shs$3.70 million07/07/2025$0.67$0.66-1.74%$0.69$0.65158,566 shs$3.15 million Get the Latest News and Ratings for ZVSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025$0.67$0.67$0.69$0.67133,409 shs$3.21 million07/03/2025$0.70$0.67-4.00%$0.69$0.67133,409 shs$3.21 million07/02/2025$0.65$0.70+7.53%$0.71$0.65432,741 shs$3.34 million07/01/2025$0.68$0.65-3.85%$0.67$0.63247,508 shs$3.11 million06/30/2025$0.71$0.68-4.96%$0.70$0.65290,397 shs$3.23 million06/27/2025$0.68$0.71+4.86%$0.73$0.66450,549 shs$3.40 million06/26/2025$0.71$0.68-4.31%$0.72$0.651.00 million shs$3.24 million06/25/2025$0.66$0.71+7.58%$0.73$0.6113.29 million shs$3.39 million06/24/2025$0.62$0.66+5.92%$0.69$0.63397,206 shs$3.15 million06/23/2025$0.65$0.62-3.54%$0.67$0.61215,102 shs$2.97 million06/20/2025$0.69$0.65-6.38%$0.71$0.65265,100 shs$3.08 million06/19/2025$0.69$0.69$0.72$0.641.14 million shs$3.29 million Related Companies MBIO Stock Price Chart CYCN Stock Price Chart PHXM Stock Price Chart ARTL Stock Price Chart SNSE Stock Price Chart LSB Stock Price Chart GLYC Stock Price Chart GNPX Stock Price Chart TLPH Stock Price Chart DWTX Stock Price Chart Receive ZVSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZVSA) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
